TABLE 1.
Baseline, end of follow-up, and changes during follow-up (Δ) values in main clinical and biochemical features of study subjects (n = 175), grouped according to the development (or not) of NAFLD at the end of follow-up
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.